DK3854388T3 - Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof - Google Patents

Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof Download PDF

Info

Publication number
DK3854388T3
DK3854388T3 DK20153621.6T DK20153621T DK3854388T3 DK 3854388 T3 DK3854388 T3 DK 3854388T3 DK 20153621 T DK20153621 T DK 20153621T DK 3854388 T3 DK3854388 T3 DK 3854388T3
Authority
DK
Denmark
Prior art keywords
rotigotin
aminine
silicone adhesive
therapeutic system
transdermal therapeutic
Prior art date
Application number
DK20153621.6T
Other languages
English (en)
Inventor
Christian Benda
Ulrike Kolling
Björn Schurad
Gabriel Wauer
Original Assignee
Luye Pharma Switzerland Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Luye Pharma Switzerland Ag filed Critical Luye Pharma Switzerland Ag
Application granted granted Critical
Publication of DK3854388T3 publication Critical patent/DK3854388T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK20153621.6T 2020-01-24 2020-01-24 Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof DK3854388T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20153621.6A EP3854388B1 (de) 2020-01-24 2020-01-24 Transdermales therapeutisches system mit dem wirkstoff rotigotin und mindestens einem nicht aminresistenten silikonkleber

Publications (1)

Publication Number Publication Date
DK3854388T3 true DK3854388T3 (da) 2023-11-27

Family

ID=69191982

Family Applications (2)

Application Number Title Priority Date Filing Date
DK20153621.6T DK3854388T3 (da) 2020-01-24 2020-01-24 Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof
DK21702196.3T DK4093383T3 (da) 2020-01-24 2021-01-22 Ransdermalt terapeutisk system med den aktive ingrediens rotigotin og mindst en ikke-aminresistent silikoneklæber

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK21702196.3T DK4093383T3 (da) 2020-01-24 2021-01-22 Ransdermalt terapeutisk system med den aktive ingrediens rotigotin og mindst en ikke-aminresistent silikoneklæber

Country Status (19)

Country Link
US (1) US20230218539A1 (da)
EP (2) EP3854388B1 (da)
JP (1) JP7835678B2 (da)
KR (1) KR20220131941A (da)
CN (1) CN115279351B (da)
AU (1) AU2021210611B2 (da)
BR (1) BR112022014665A2 (da)
CA (1) CA3165453A1 (da)
CL (1) CL2022001988A1 (da)
CO (1) CO2022011900A2 (da)
DK (2) DK3854388T3 (da)
ES (2) ES2966170T3 (da)
FI (2) FI3854388T3 (da)
HR (1) HRP20251425T1 (da)
MX (1) MX2022009114A (da)
PL (2) PL3854388T3 (da)
PT (2) PT3854388T (da)
SI (1) SI4093383T1 (da)
WO (1) WO2021148634A1 (da)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4591622A (en) 1984-10-29 1986-05-27 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product thereof
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
DE19830898A1 (de) 1998-07-10 2000-01-13 Hexal Ag Vorrichtung zur Verbesserung der Entnahmefähigkeit von in Beuteln verpackten, haftklebend ausgerüsteten, flächigen Substratabschnitten
US6337086B1 (en) * 1999-02-06 2002-01-08 Dow Corning Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
WO2002024157A2 (en) 2000-09-19 2002-03-28 National Starch And Chemical Investment Holding Corporation Acryl adhesive useful in transdermal drug delivery systems
PT1256339E (pt) 2001-05-08 2004-02-27 Lohmann Therapie Syst Lts Sistema terapeutico transdermico para doenca de parkinson que induz niveis plasmaticos altos de rotigotina
EP1256340B1 (en) 2001-05-08 2003-08-13 Schwarz Pharma Ag Improved transdermal therapeutic system for the treatment of Parkinson's disease
DE10220230A1 (de) 2002-05-06 2003-11-27 Sanol Arznei Schwarz Gmbh Verwendung von Rotigotine zur Behandlung des Restless Leg Syndroms
DE10234673B4 (de) * 2002-07-30 2007-08-16 Schwarz Pharma Ag Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
EP1386605A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system for the administration of rotigotine
EP1386604A1 (en) 2002-07-30 2004-02-04 Schwarz Pharma Ag Improved transdermal delivery system
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
DE10361259A1 (de) 2003-12-24 2005-07-28 Schwarz Pharma Ag Verwendung von Rotigotine in einem Frühstadium von Morbus Parkinson zur Prävention des weiteren Neuronenverlustes
DE102004014841B4 (de) 2004-03-24 2006-07-06 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung und Prävention des Parkinson-Plus-Syndroms
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
SI2215072T1 (sl) 2007-11-28 2015-10-30 Ucb Pharma Gmbh Polimorfna oblika rotigotina
WO2009158120A2 (en) * 2008-05-30 2009-12-30 Mylan Laboratories Inc. Stabilized transdermal drug delivery system
EP2298277A1 (en) * 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
DE102009052972A1 (de) 2009-11-12 2011-09-15 Lts Lohmann Therapie-Systeme Ag Verfahren zur Verhinderung der Kristallisation von Arzneistoffen in einem Polymerfilm
US9925150B2 (en) * 2009-12-22 2018-03-27 Lts Lohmann Therapie-Systeme Ag Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotine
EP2457565A1 (de) 2010-11-29 2012-05-30 Ratiopharm GmbH Transdermales therapeutisches System enthaltend Rotigotin
WO2012084969A1 (en) 2010-12-22 2012-06-28 Hexal Ag Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
US11534523B2 (en) * 2011-08-30 2022-12-27 Avery Dennison Corporation Silicone absorbent adhesive layer
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
US20160199316A1 (en) * 2013-06-14 2016-07-14 Tesa Labtec Gmbh Three-layer transdermal therapy system (tts)
WO2015177209A1 (en) * 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
WO2018143384A1 (ja) 2017-02-03 2018-08-09 コスメディ製薬株式会社 ロチゴチン含有経皮吸収型貼付剤
CN109806243B (zh) * 2017-11-20 2022-07-15 北京泰德制药股份有限公司 一种含有氟吡汀或其药用盐的皮肤外用贴剂

Also Published As

Publication number Publication date
FI3854388T3 (fi) 2023-11-27
MX2022009114A (es) 2022-10-27
AU2021210611B2 (en) 2025-12-18
SI4093383T1 (sl) 2026-01-30
CN115279351A (zh) 2022-11-01
AU2021210611A1 (en) 2022-08-18
CL2022001988A1 (es) 2023-05-19
PL3854388T3 (pl) 2024-02-26
PT3854388T (pt) 2023-12-11
WO2021148634A1 (de) 2021-07-29
EP3854388A1 (de) 2021-07-28
HRP20251425T1 (hr) 2026-01-30
JP2023511964A (ja) 2023-03-23
CO2022011900A2 (es) 2022-10-31
ES2966170T3 (es) 2024-04-18
US20230218539A1 (en) 2023-07-13
PL4093383T3 (pl) 2026-03-09
CN115279351B (zh) 2026-03-10
EP3854388B1 (de) 2023-10-04
KR20220131941A (ko) 2022-09-29
DK4093383T3 (da) 2025-12-01
ES3051624T3 (en) 2025-12-29
JP7835678B2 (ja) 2026-03-25
EP4093383A1 (de) 2022-11-30
EP4093383B1 (de) 2025-08-27
BR112022014665A2 (pt) 2022-10-11
PT4093383T (pt) 2025-11-25
FI4093383T3 (fi) 2025-11-28
CA3165453A1 (en) 2021-07-29

Similar Documents

Publication Publication Date Title
EP4491136A4 (en) Shock wave electrode device and shock wave catheter system
EP4246953A4 (en) Configuration method and apparatus
DK3960260T3 (da) Kropsbåren enhed og metode deraf
DK4051377T3 (da) Terapeutisk indretning til smertefulde inflammationssygdomme og til neuromuskulær og neuropostal modulation
EP4378346A4 (en) WEARABLE DEVICE AND WEARABLE SYSTEM
EP4560455A4 (en) DISPLAY METHOD AND DEVICE
EP4266293A4 (en) Display device and display system
EP4645293A4 (en) DISPLAY DEVICE AND DISPLAY SYSTEM
EP4467094C0 (en) SKIN TREATMENT DEVICE
EP4159270A4 (en) Electrode plate and wearable defibrillation device
ES2957905R1 (es) Cateter medico y aparato medico
DK3854388T3 (da) Transdermalt terapeutisk system omfattende rotigotin og mindst et ikke-aminresistent silikoneklæbestof
DK4255563T3 (da) 5´-o-phenylacetyluridin og terapeutisk anvendelse
EP4204083A4 (en) PATIENT SUPPORT FOR TELETHERAPY AND METHOD
EP4262289A4 (en) Configuration method and apparatus
DK3950803T3 (da) Selvklæbende silikonegelsammensætning og silikonegel omfattende et hærdet produkt deraf
EP4561712A4 (en) FALL PROTECTION COMPLIANCE SYSTEM AND METHOD
EP4302707A4 (en) RETRACTOR AND HOLDER
PL4327419T3 (pl) Urządzenie superponujące oraz układ optyczny
EP3919107C0 (de) Atemtherapiegerät
DK3866544T3 (da) Fremgangsmåde og anordning til identitetssamling
DK4436543T3 (da) Slimhindesugeplaster og anvendelser deraf til lægemidlering
EP4642342A4 (en) APPARATUS AND METHOD OF VERTEBRAL TREATMENT
TH2102001403S (th) อุปกรณ์รองรับข้อมือและข้อเท้า
EP4597938A4 (en) MIGRATION METHOD AND APPARATUS